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Abstract
Background: Low birth weight is associated with an increased risk of developing impaired glucose tolerance, and
eventually type 2 diabetes in adult life. Gestational protein restriction in rodents gives rise to a low birth weight
phenotype in the offspring.
Results: We examined gene expression changes in liver and skeletal muscle of mice subjected to gestational protein
restriction (LP) or not (NP), with or without taurine supplementation in the drinking water. LP offspring had a 40% lower
birth weight than NP offspring, with taurine preventing half the decrease. Microarray gene expression analysis of
newborn mice revealed significant changes in 2012 genes in liver and 967 genes in skeletal muscle of LP offspring.
Taurine prevented 30% and 46% of these expression changes, respectively. Mitochondrial genes, especially those
involved with oxidative phosphorylation, were more abundantly changed than other genes. The mitochondrial genes
were mainly upregulated in liver, but downregulated in skeletal muscle, despite no change in citrate synthase activity in
either tissue. Taurine preferentially rescued genes concerned with fatty acid metabolism in liver and with oxidative
phosphorylation and TCA cycle in skeletal muscle. A mitochondrial signature was seen in the liver of NP offspring with
taurine supplementation, as gene sets for mitochondrial ribosome as well as lipid metabolism were over represented in
4-week-old offspring subjected to gestational taurine supplementation. Likewise, 11 mitochondrial genes were
significantly upregulated by gestational taurine supplementation in 4-week-old NP offspring.
Conclusions: Gestational protein restriction resulted in lower birth weight associated with significant gene
expression changes, which was different in liver and muscle of offspring. However, a major part of the birth weight
decrease and the expression changes were prevented by maternal taurine supplementation, implying taurine is a
key factor in determining expression patterns during development and in that respect also an important
component in metabolic fetal programming.
Background
Low birth weight is associated with increased risk of devel-
oping an abnormal metabolic phenotype such as obesity
and type 2 diabetes [1] in later life [2] and is in humans
associated with impaired insulin signaling in skeletal mus-
cle [3-5], hepatic insulin resistance [6], and decreased insu-
lin secretion [7] in adult life. However, the exact
mechanism by which impaired fetal growth confers insulin
resistance is unknown, although recently mitochondrial
oxidative stress was proposed as a possible mechanism [8].
Animal models mimicking impaired fetal growth all dis-
play dysregulated glucose metabolism and altered insulin
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where dams are fed a low protein (LP) diet during preg-
nancy, is one such model [9] and although most studies
have focused on betal-cell dysfunction [9], an increase in
peripheral insulin sensitivity in young animals [10] and a
decrease in old animals [11,12] has been observed in off-
spring subjected to a maternal low protein diet.
Taurine, a sulfur-containing amino acid which does
not enter protein synthesis, has a number of physiologi-
cal functions such as conjugation with bile acids, osmo-
tic pressure regulation in brain and antioxidant
properties. Additionally, taurine functions as a chemical
chaperone in conjugation with ursodeoxycholic acid,
thereby relieving ER stress, and may be required for
optimal mitochondrial protein synthesis, as taurine con-
jugation of one mitochondrial tRNA is required for opti-
mal function tRNA [13]. Taurine has also been
suggested to be involved in skeletal muscle fatigue, most
likely due to a mitochondrial effect [14] (for reviews, see
[15,16]). Furthermore, taurine lowers blood glucose in
type 2 diabetic patients [16,17] and has in rodents been
shown to be able to prevent or delay development of
insulin resistance induced by fructose-overfeeding in
rodents [18]. Taurine ameliorates some of the harmful
effects that gestational protein restriction confers upon
the pancreas of the offspring by normalizing prolifera-
tion [19], vascularization, and decreasing sensitivity
towards cytokines in pancreatic islets [20]. Collectively,
these studies suggest that taurine has a profound impact
on gene expression, a ‘reprogramming’ or rescuing
effect, during fetal development, perhaps via epigenetic
and/or organogenesis related mechanisms.
In the present study, we examined the effect of mater-
nal taurine supplementation upon the offspring of gesta-
tional protein restriction by gene expression profiling of
liver and skeletal muscle.
Experimental procedures
Animals
Virgin female (7-8 weeks old, N=3 per diet group)
C57BL/6 mice (Taconic, Ejby, Denmark) were mated
with C57BL/6 male mice. Following observation of a
vaginal plug (gestation day 0), the mice were rando-
mized into four different diet groups: Normal protein
(20% casein; NP; Hope Farms 4400.00, Woerden, NL) or
low protein (8% casein; LP; Hope Farms 4400.01), both
with no detectable taurine, with or without 1% (w/v)
taurine in the drinking water (tau, i.e. NP+tau or LP
+tau) (synthetic taurine; Sigma-Aldrich, St. Louis, MO,
USA).
The four different diet groups were considered largely
isocaloric since taurine supplementation only marginally
contributes to the calorie intake as taurine is not meta-
bolized and cannot make up for the decreased intake of
essential amino acids caused by the LP diet. Mice were
kept in a 12-hour light/dark cycle. At day 19 the mice
gave birth and newborn pups were weighed, killed by
decapitation and liver and hind leg skeletal muscle
quickly and quantitatively removed, weighed, quick fro-
z e ni nl i q u i dn i t r o g e na n ds t o r e da t- 8 0° Cf o rf u r t h e r
analysis. For the newborn mice, a total of 25 pups from
12 different dams were analyzed, with 5≤n≤7p u p sp e r
group, all groups being a mixture of male and female
pups. For examination of an effect of taurine upon NP
offspring, 3 animals from NP and NP+tau were sacri-
f i c e da t4w e e k so fa g e ,f o l l o w e db yd e c a p i t a t i o n ,q u i c k
removal of liver and quadriceps muscle. Tissue was
quick frozen in liquid nitrogen and stored at -80 °C
until further analysis. All experimental procedures were
approved by The National Committee on Animal
Experimentation, Denmark and by the local animal facil-
ity at the University of Copenhagen, Denmark.
RNA preparation
RNA was extracted from muscle and liver tissue using
Trizol (Invitrogen, Carlsbad, CA, USA) as described by
the manufacturer. In brief, tissue was homogenized in
Trizol with a 5 mm steel bead, using a Qiagen Tissuely-
zer (Qiagen). Upon lysis, RNA was extracted with
chloroform and precipitated using isopropanol. Finally,
RNA was subjected to cleanup using RNeasy columns
(Qiagen). RNA quality was assured using a Bioanalyzer
(Agilent, Santa Clara, CA, USA).
Microarray experiment
Three randomly selected samples of RNA from each of
the four dietary groups as well as from the 4-week-old
NP and NP+tau groups were analyzed at the RH Micro-
array Center (Rigshospitalet, Copenhagen, Denmark).
RNA labelling, Affymetrix Mouse 430 2.0 array (Affyme-
trix Inc., Santa Clara, CA, USA) hybridization, and scan-
ning were performed according to the manufacturer’s
instructions. Each pup used was from a different dam,
with liver and muscle being analyzed from the same ani-
mal. It was ensured that all groups constituted either
one male and two females or one female and two male
pups. Arrays from liver and muscle were processed and
analyzed separately as described below. Samples from
the 4-week-old animals were also analyzed separately.
Raw CEL files from all groups were normalized using
quantile normalization, and log2 probe expression values
were obtained using RMA in one step using justRMA (R
2.7.0 and Bioconductor 2.2 [21]). Control probes and
probes not present on at least one microarray (accord-
ing to MAS5 absent present calls) were removed before
further analysis. For statistical analysis of the remaining
probes a strategy of pre-selecting probes for subsequent
2-way analysis of variance (ANOVA) was adopted.
Mortensen et al. Journal of Biomedical Science 2010, 17(Suppl 1):S38
http://www.jbiomedsci.com/content/17/S1/S38
Page 2 of 11Using significance analysis of microarrays (SAM) [22],
we selected genes that were different between the fol-
lowing pairs of groups with a false discovery rate (FDR)
of less than 10%: NP vs NP+tau, NP vs. LP, NP+tau vs.
LP+tau, and LP vs. LP+tau. The resulting list of signifi-
cantly changed probes were then analyzed using a 2-way
ANOVA model: log2(probe expression level) = protein
taurine protein*taurine, withp < 0 . 0 5c o n s i d e r e ds i g n i f i -
cant. Due to the previous SAM pre-selection, no adjust-
ment for multiple testing was done. Finally, this list of
probes was subjected to a student’s t-test examining
whether or not there was a significant (p<0.05) differ-
ence between NP and LP. In case of multiple probes for
the same gene, the probe with the best rescue effect (see
below) was chosen, and in the case of multiple probes
having the same rescue effect the probe with the highest
average expression level in NP was chosen. The result-
ing list was annotated using Bioconductor 2.2 and
manually curated, and genes considered unknown
(expressed sequence tags, putative genes, RIKEN cDNAs
etc.) were removed.
Changes in gene expression levels caused by the
maternal LP diet were considered fully rescued by taur-
ine when the following criteria assessed by students’ t-
tests were met: 1) The gene expression level of LP and
LP+tau must be significantly different (p<0.05), and 2)
the gene expression level between NP and LP+tau must
not be significantly different (p>0.05). Likewise, a gene
was considered partially rescued if: 1) The gene expres-
sion level between LP and LP+tau was significantly dif-
ferent (p<0.05) and 2) LP+tau confer a change in the
opposite direction of LP compared to NP.
No differences in gene expression were found when
directly comparing NP or NP+tau diet offspring with LP
+tau offspring using SAM (FDR<10%, data not shown)
in both liver and skeletal muscle. Others have used this
as proof of a total phenotype reversal [23], however the
a b o v em o r ef i n e - g r a i n e da n a l y s i ss h o wo n l yap a r t i a l
rescue effect of taurine.
Cluster analyses were carried out on log2 expression
values using dChip [24], clustering both samples and
genes, standardized to row means, with precalculated
correlation distances using average linkage. Over-repre-
sentation of specific gene sets among the genes signifi-
cantly changed by an LP diet, were estimated using
DAVID 2008 [25] with probe ids for the unique genes
as input compared against a list of probe ids for known
unique genes without control genes and probes without
a valid EntrezGene id as background. Fishers exact test
was used to examine if taurine selectively rescued speci-
fic gene sets rather than having a general rescue effect
on all genes. Gene annotations were carried out using
information from DAVID 2008 and Genecards (http://
www.genecards.org) [26]. Mitochondrial genes were
assessed as genes with a GO cellular compartment term
containing either mitochondrial or mitochondrion. All
statistical analyses on microarray data were performed
using R 2.7.0.
In order to detect changes in gene expression caused
by gestational taurine supplementation in 4-week-old
offspring (NP+tau vs. NP), 4-week samples were nor-
malized by tissue as above and probes not present on at
least one microarray (according to MAS5 absent present
calls) were removed. Following this, a gene set enrich-
ment analysis (GSEA) [27] was performed with the GO
cellular compartments (CC) and KEGG genesets using
standard parameters. Furthermore, a subset probeset
consisting of mitochondrial genes (GO CC containing
mitochon*) were subjected to a SAM analysis examining
differences between NP and NP+tau in both 0- and 4-
week animals, with an FDR of less than 10% considered
significant. The data discussed in this publication have
been deposited in NCBIs Gene Expression Omnibus
(GEO, http://www.ncbi.nlm.nih.gov/geo) [28] and are
accessible through GEO series accession number
GSE12730 (newborn samples) and GSE20577 (4 week
samples).
Biochemical measurements
A 5% (wt/vol) homogenate of skeletal muscle tissue was
prepared in a 2-ml Potter-Elvehjem glass-teflon homo-
genizer for 1 min at 0 °C in a buffer containing 25 mM
glycyl-glycin, 150 mM KCl, 5 mM MgSO4, 5 mM
EDTA, 1mM DTT, 0.02% BSA, and 0.1% Triton X-100,
pH 7.5. The liver homogenate was prepared in the same
buffer applying a Qiagen Tissuelyzer (Qiagen, Valencia,
CA, USA) at 0 °C employing ice-cold racks, homogeniz-
i n gf o r3t i m e s1m i na t3 0H z .T h eh o m o g e n a t ew a s
frozen in liquid nitrogen, thawed on ice, whirl mixed,
and centrifuged at 22,000 g for 2 min at 4 °C. The
supernatant was stored at -80 °C for determination of
enzyme activities and protein concentration. Protein
content was measured using BSA (fraction V) as stan-
dard [29]. Citrate synthase (CS, EC 4.1.3.7) activity was
determined as described previously [30] and expressed
relative to the total protein content as units per mg
protein.
Quantitative real-time RT-PCR
Reverse transcription (RT) reactions were performed
using random hexamers on 2 µg RNA using an RT kit
(Applied Biosystems, Foster City, CA) in a reaction
volume of 100 µl. The resulting cDNA product was
stored at -20 °C until further analysis. The primers and
probes for all genes and the 18S rRNA endogenous con-
trol were pre-developed TaqMan probes and primer sets
from Applied Biosystems: ACSS2 (acyl-CoA synthetase
short-chain family member 2; Mm00480101_m1),
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Page 3 of 11COX7A1 (cytochrome c oxidase, subunit VIIa 1;
Mm00438296_m1), COX7C (cytochrome c oxidase, sub-
unit VIIc; Mm01340476_m1), CS (citrate synthase;
Mm00466043_m1), EGFR (epidermal growth factor
receptor; Mm00433023_m1), FST (Follistatin;
Mm00514982_m1), GLDC (glycine decarboxylase;
Mm00506891_m1), GPD2 (glycerol phosphate dehydro-
genase 2, mitochondrial; Mm00439082_m1), MH1
(myosin, heavy polypeptide 1, skeletal muscle, adult;
Mm01332489_m1), MYBPC2 (myosin binding protein
C, fast-type; Mm00525419_m1), PDK4 (pyruvate dehy-
drogenase kinase, isoenzyme 4; Mm00443325_m1),
SPP1 (secreted phosphoprotein 1; Mm00436767_m1),
UCP3 (uncoupling protein 3 (mitochondrial, proton car-
rier); Mm00494074_m1) PGC-1a (peroxisome prolifera-
tor receptor g coactivator 1; Mm00447183_m1). All
assay reagents were from Applied Biosystems. The
mRNA levels of all genes and the endogenous control,
18S rRNA, were determined by real time RT-PCR using
an ABI PRISM 7900 sequence detector (Applied Biosys-
tems). The amplification mixtures were amplified
according to standard conditions using 50 cycles in a 10
µl volume in triplicate. The relative mRNA content of
both the target and the endogenous control gene was
calculated from the cycle threshold values by using a
standard curve constructed from a serial dilution of ali-
quots of cDNA pooled from all the samples. The rela-
tive expression levels of all genes were determined by
normalization to the endogenous control, 18S rRNA,
which was found not to differ between diet groups.
Statistics
Birthweight, liver and muscle weight as well as all
enzyme activity data exhibited a normal distribution,
and data are presented as means ± standard error of the
mean (SEM). All microarray and mRNA data were log-
transformed in order to obtain a normal distribution,
and data are presented as geometric means with 95%
confidence intervals. Statistical analyses were carried out
using a 2-way ANOVA with Bonferroni corrected stu-
dents’ t-tests as post hoc tests. All statistical analyses
were performed using SAS 9.1.2 (The SAS Institute),
except for the microarray analysis which was performed
as described above. A p value<0 . 0 5w a sc o n s i d e r e d
significant.
Results
Birthweight and citrate synthase enzyme activity in liver
and muscle of newborn mice
Mouse dams were subjected to four different isocalo-
r i cd i e tr e g i m e sf r o md a y1o fp r e g n a n c yu n t i lg i v i n g
birth as described in materials and methods. The LP
diet caused a ~40 % decrease (p<0.001) of the birth-
weight of the pups (Table 1). Supplementing the
maternal LP diet with taurine reduced the birthweight
loss by half (p<0.01) (Table 1). Both liver and skeletal
muscle mass of newborn pups were decreased in pro-
p o r t i o nt ob o d yw e i g h tb yt h em a t e r n a lL Pd i e t( d a t a
not shown).
As a measure of the mitochondrial fraction of tissue
mass, citrate synthase (CS) specific enzyme activity and
mRNA level [31] was determined in liver and skeletal
muscle of the newborn pups. There was no difference
between diet groups in CS enzyme specific activities
(Table 1) or mRNA levels (see Additional file 1).
Taurine partially rescues the effects of gestational protein
restriction on gene expression levels in liver and skeletal
muscle of newborn mice
Gene expression profiles of three randomly chosen new-
born offspring samples from each diet group of both
liver and skeletal muscle were analyzed using Affymetrix
gene expression microarrays as described in materials
and methods (Table 2).
In liver, the expression of a total of 2012 non-redun-
dant transcripts, all encoding known genes, were signifi-
cantly changed by the maternal LP diet, while a
somewhat smaller number (967) of non-redundant tran-
scripts, all encoding known genes, were changed in ske-
letal muscle (Table 2). Of the 2012 genes affected in the
liver, 667 transcripts were up- and 1345 down-regulated.
Similarly, in skeletal muscle; of the 967 genes affected,
312 were up- and 655 transcripts were down-regulated
compared with a maternal NP diet (Table 2).
Table 1 Maternal low protein diet effects on body mass and citrate synthase activity in newborn mice
Taurine - + - + 2-way ANOVA
Protein NP NP LP LP chow taurine c*t
Body mass (g) 1.23±0.03 1.15±0.05 0.72±0.05 1.01±0.06
**,* 0.0001 0.037 0.0008
CS liver (mU/mg) 80.2±5.7 85.1±2.5 74.7±4.3 75.6±3.8 (0.0825) ns ns
CS muscle (mU/mg) 127.1±12.2 133.1±8.5 140.7±15.3 149.9±13.4 ns ns ns
Newborn mice subjected to different diet regimes in utero as described in materials and methods were weighed at birth and killed. Liver and skeletal muscle
tissue were extracted, and citrate synthase (CS; mU/mg protein) enzyme activity measured as described. BM) Body mass, NP) normal protein (20% casein)o rL P )
low protein (8% casein) during pregnancy. Taurine) 1% taurine supplementation in the drinking water during pregnancy. Bonferroni corrected post hoc t-tests
performed if chow*taurine (c*t) interaction was significant: ¶) p<0.001 NP vs. LP, **) p<0.01 LP vs. LP+taurine, *) p<0.05 NP vs. LP+taurine. All values are shown
as means ± SEM. 5 ≤ N ≤ 7 per diet group.
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one not significantly changed (CS) were randomly
selected for RT-PCR validation of the microarray
data. Positive validation was obtained for 7 out of 8
and 6 out of 9 transcripts encoding known genes in
liver and skeletal muscle, respectively (see Additional
file 1).
Taurine supplementation prevented a major part of
the gene expression changes seen with the maternal LP
diet (Table 2). Taurine had a rescuing effect on 30%
Table 2 General data from the microarray analyses
Description Liver Muscle
Total number of probes on the Affymetrix Mouse 430 2.0 gene expression array 45101 45101
Number of probes present on at least one array 28653 30966
Above without control probes or probes without a valid EntrezGene identifier 27300 29443
Probes significantly changed in SAM preprocessing (FDR<10%) 6047 1559
Probes significantly changed (p<0.05) in two-way ANOVA 3678 1284
Probes significantly different (p<0.05) between NP and LP 2827 1272
Unique genes significantly different (p<0.05) between NP and LP 2363 1110
Known genes significantly different (p<0.05) between NP and LP 2012 967
Known genes different between NP and LP and fully rescued by taurine 510 423
Known genes different between NP and LP and partially rescued by taurine 90 21
Total number of known genes rescued by taurine 600 444
Percentage known genes different between NP and LP rescued by taurine 30% 46%
A list of probe or gene numbers detailing the microarray gene expression analyses of liver and skeletal muscle of newborn mice, as described. NP) normal
protein (20% casein) or LP) low protein (8% casein) during pregnancy. Table reprinted with permission from Wolters Kluwer Health / Lippincott Williams &
Wilkins. [52]
Table 3 Analysis of gene set over-representation in liver newborn mice
Ease Taurine Average fold change
Category Count score % Rescued score NP NP+tau LP LP+tau
All genes 2012 na 30% na 1 0.96 0.95 0.96
KEGG pathway analysis 620 na 31% na 1 0.97 1.02 1.01
Oxidative phosphorylation 42 1.56E-06 43% 0.125 1 1.06 1.44 1.21
Valine, leucine and isoleucine degradation 17 3.13E-03 24% 0.604 1 1.04 1.47 1.27
Lysine degradation 17 4.12E-03 41% 0.428 1 1.02 1.40 1.24
Butanoate metabolism 15 2.04E-02 27% 1 1 0.99 1.16 1.19
Limonene and pinene degradation 10 2.06E-02 20% 0.732 1 0.98 1.15 1.14
Panther biological pathways 1965 na 30% na 1 0.96 0.95 0.96
Fatty acid metabolism 122 7.90E-05 40% 0.027 1 0.95 0.86 0.94
Protein disulfide-isomerase reaction 90 1.16E-04 29% 0.907 1 0.99 1.04 1.01
Oxidative phosphorylation 175 1.63E-03 28% 0.606 1 0.94 0.97 0.97
Immunity and defense 171 2.34E-03 30% 1 1 0.99 0.86 0.95
Carbohydrate metabolism 86 4.54E-03 32% 0.722 1 0.97 1.07 1.05
GO cellular component 1627 na 30% na 1 0.96 0.95 0.96
mitochondrion 209 4.71E-11 37% 0.057 1 1.03 1.29 1.13
Cytoplasm 866 4.53E-08 nd nd nd nd nd nd
Intracellular part 1231 2.51E-07 nd nd nd nd nd nd
mitochondrial inner membrane 68 1.21E-06 nd nd nd nd nd nd
organelle inner membrane 69 3.63E-06 nd nd nd nd nd nd
Genes found to have their expression level significantly changed in liver in newborn mice subjected to a maternal low protein diet compared to a normal diet
were examined for over-representation of specific gene sets as described. The top 5 most significant over-represented gene sets are shown. Count) Total number
of genes in analysis. Ease score) a modified fishers exact test describing the probability of gene set enrichment. % Rescued) Amount of rescued or partially
rescued genes (see table 2 and materials and methods) in percent of count. Taurine score) Fishers exact test examining if taurine preferentially rescued the gene
set compared to the rescue effect seen in all genes examined in the parent geneset. Average fold change) Means of fold change for the 4 diet groups per gene
set in regard to NP. NP) normal protein (20% casein) or LP) low protein (8% casein) during pregnancy, tau) 1% taurine supplementation in the drinking water
during pregnancy. na) not applicable. nd) not determined. Table reprinted with permission from Wolters Kluwer Health / Lippincott Williams & Wilkins. [52]
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genes in liver and on 46% (444 out of 967) in skeletal
muscle (Table 2), rendering the taurine effect more pro-
nounced on muscle than on liver (p<10
-16, Fishers exact
test).
Among the changed genes, we found that mitochon-
drial genes and among those in particular genes
involved in oxidative phosphorylation were over-repre-
sented in both liver and skeletal muscle (Table 3 and
4). Genes involved in the TCA cycle, pyruvate dehy-
drogenase and glycolysis were over-represented only in
skeletal muscle (Table 4). Over-representation of genes
involved in amino acid metabolism was observed both
in liver and skeletal muscle (Table 3 and 4). However,
the key regulator of mitochondrial biogenesis, peroxi-
some proliferator-activated receptor g coactivator-1a
(PGC-1a), was downregulated by the LP diet in both
tissues (see Additional file 1) and was not affected by
taurine.
When genes were grouped according to function (fig-
ure 1A) (see Additional file 2), a large difference was
seen between up and down-regulated genes involved in
energy metabolism (figure 1A) in both liver and skeletal
muscle., albeit in a different direction in the two tissues.
Likewise, when mitochondrial genes were grouped
according to function, a clear difference between liver
and skeletal muscle could be seen (figure 1B) (see Addi-
tional file 3 and 4). The rescuing effect of taurine was
significantly higher on genes involved in fatty acid meta-
bolism in liver compared to other gene sets (Table 3),
whereas in skeletal muscle this rescuing effect was pre-
sent only for genes involved in oxidative phosphoryla-
tion and the TCA cycle (Table 4).
Gestational taurine supplementation has a lasting effect
Since taurine primarily affected mitochondrial genes
changed by the gestational low protein diet, it is of
interest to note that we did not find any effect of taurine
on the newborn offspring of dams fed an NP diet during
gestation. However, in 4-week-old offspring a subset of
mitochondrial genes involved in the mitochondrial ribo-
some function were upregulated in liver (Table 5). In
muscle there was an increase (SAM, FDR < 10%) in 11
mitochondrial genes, including genes involved in lipid
Table 4 Analysis of gene set over-representation in skeletal muscle in newborn mice
Ease Taurine Average fold change
Category Count score % Rescued score NP NP+tau LP LP+tau
All genes 967 na 46% na 1 0.98 0.95 0.94
KEGG pathway analysis 263 na 46% na 1 0.99 0.90 0.93
Oxidative phosphorylation 24 5.60E-06 75% 0.010 1 0.92 0.72 1.04
Citrate cycle (TCA cycle) 8 2.45E-03 88% 0.029 1 0.96 0.58 0.93
Valine, leucine and isoleucine degradation 10 4.53E-03 40% 0.757 1 1.02 0.59 0.81
Pyruvate metabolism 9 9.62E-03 67% 0.314 1 0.99 0.49 0.86
Glycolysis / Gluconeogenesis 10 1.12E-02 60% 0.523 1 0.96 0.61 0.98
Panther biological pathways 928 na 46% na 1 0.98 0.94 0.94
Electron transport 65 3.99E-04 45% 1 1 0.96 0.84 0.98
Muscle contraction 13 5.12E-03 64% 0.189 1 0.84 0.38 0.84
Cell adhesion-mediated signaling 33 5.85E-03 52% 0.596 1 0.99 1.06 0.99
Cell motility 48 9.44E-03 44% 0.769 1 1.00 1.16 0.97
Ion transport 133 1.21E-02 53% 0.164 1 0.97 0.94 0.93
GO cellular component 777 na 47% na 1 0.98 0.94 0.94
Mitochondrion 121 2.46E-13 56% 0.065 1 0.97 0.62 0.91
cytoplasmic part 288 8.48E-10 nd nd nd nd nd nd
Cytoplasm 441 1.57E-09 nd nd nd nd nd nd
mitochondrial part 56 4.70E-09 nd nd nd nd nd nd
mitochondrial inner membrane 42 1.12E-07 nd nd nd nd nd nd
Genes found to have their expression level significantly changed in skeletal muscle in newborn mice subjected to a maternal low protein diet compared to a
normal diet were examined for over-representation of specific gene sets as described. The top 5 most significant over-represented gene sets are shown. Count)
Total number of genes in analysis. Ease score) a modified fishers exact test describing the probability of gene set enrichment. % Rescued) Amount of rescued or
partially rescued genes (see table 2 and materials and methods) in percent of count. Taurine score) Fishers exact test examining if taurine preferentially rescued
the gene set compared to the rescue effect seen in all genes examined in the parent geneset. Average fold change) Means of fold change for the 4 diet groups
per gene set in regard to NP. NP) normal protein (20% casein) or LP) low protein (8% casein) during pregnancy, tau) 1% taurine supplementation in the drinking
water during pregnancy. na) not applicable. nd) not determined. Table reprinted with permission from Wolters Kluwer Health / Lippincott Williams & Wilkins. [52]
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Page 6 of 11metabolism (carnitine palmitoyl transferase 2), methio-
nine metabolism (Methionine sulfoxide reductase B2)
and mitochondrial rRNA methylation (mitochondrial
rRNA methyltransferase 1), (Table 6).
Discusson
The novel findings of this study were 1) that a mater-
nal low protein diet induced substantial changes in
gene expression patterns in newborn offspring in both
liver and skeletal muscle, 2) that the changes in mito-
chondrial genes in general and genes of oxidative
phosphorylation in particular were prominent in both
liver and skeletal muscle, with predominantly upregu-
lation in liver and downregulation in skeletal muscle,
3) that maternal taurine supplementation in the drink-
ing water during pregnancy to a surprisingly large
extent prevented these changes in gene expression pat-
terns in both liver and skeletal muscle, and finally 4)
that gestational taurine supplemention of control dams
during gestation seemed to have an effect upon mito-
chondrial gene expression in the offspring at 4 weeks
of age.
Figure 1 Classification of changed genes by biological function A) Genes significantly changed in newborn mice in response to an in utero
low protein diet in liver and skeletal muscle. For comparison, only genes that were changed in both liver and skeletal muscle are shown. B)
Mitochondrial genes changed in newborn mice in response to an in utero low protein diet in liver and skeletal muscle. Grey/black bars indicate
down/up-regulated genes in newborn mice subjected to a low protein diet in utero compared to a normal protein diet. Hatched bars indicate
the number of genes rescued by taurine supplementation. Figure reprinted with permission from Wolters Kluwer Health / Lippincott Williams &
Wilkins. [52]
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The 40% decrease in birthweight of LP offspring
observed in this study is somewhat larger than pre-
viously reported in the same mouse strain (7% and 28%)
[32]. We observed no difference in the ratio of organ
weight:total body weight, which seems to disagree with
a previous study in rats [33], and we saw a large rescue
effect of taurine upon birthweight, in disagreement with
a similar study in rats [19]. However, these disagree-
ments likely reflect species or diet composition
differences.
Changes in global gene expression patterns in liver and
skeletal muscle
Genes involved in oxidative phosphorylation and other
mitochondrial genes were the most over-represented in
the genes changed in the LP offspring (Table 3 and 4).
This suggests that dysregulation of energy metabolism is
a key component in the development of the low birth-
weight phenotype. Furthermore, as CS activity may be
considered a measure of mitochondrial mass, the lack of
ac h a n g ei nC Sa c t i v i t ys u g g e s t st h i sd y s r e g u l a t i o nm a y
happen without a change in mitochondrial mass. How-
ever, this seem to be at variance with Park et al. [34],
who reported a decreased mtDNA:gDNA ratio in both
liver and skeletal muscle in 5-week-old offspring of
maternal low protein rats.
In liver, a large fraction of genes involved in amino acid
metabolism, protein synthesis, TCA cycle and energy
metabolism genes involved in both Complex I-IV and
ATP synthesis showed an increased expression, whereas
in skeletal muscle the opposite effect was observed. The
concentration of taurine in skeletal muscle is ~6 fold
higher than in the liver in mice [35], suggesting a differ-
ent taurine requirement of the two tissues. It should also
be noted that a decrease in taurine availability is known
to occur under LP conditions [36], and that taurine is a
constituent of mitochondrial tRNA [13] and may thus be
required for normal mitochondrial function.
Downregulation of oxidative phosphorylation in skele-
tal muscle has in several cases been linked to develop-
ment of type 2 diabetes and insulin resistance [37,38].
Although the exact mechanism is unknown, a decrease
in the number of skeletal muscle mitochondria and/or
in the activity of oxidative phosphorylation as well as
mitochondrial dysfunction at birth may, if it is perma-
nent, be associated with a decreased capacity for b-oxi-
dation capacity, which may lead to increased
intracellular lipid content and subsequent disruption of
insulin signaling [39]. However, this hypothesis has
recently been questioned [40].
Interestingly, in humans birthweight is positively asso-
ciated with the expression of PGC-1a in skeletal muscle in
adults [6], but despite PGC-1a controlling mitochondrial
biogenesis [41], no concomitant difference in mitochon-
drial gene expression and oxidative phosphorylation was
observed in adults with a low birthweight [6]. However,
the decrease in mitochondrial gene expression seen in this
study and not in adult humans may reflect the difference
between newborns and adults or species difference.
Partial phenotype rescue by taurine supplementation
Taurine has previously been shown to rescue the
adverse effects of a maternal LP diet on pancreatic func-
tion in the offspring [19,20,23,42]. We find a large res-
cuing effect on gene expression profiles in both liver
Table 5 The effect of gestational taurine
supplementation on gene set enrichment analysis of 4
week old mice
Category / tissue Size ES NES FDR FWER
GO cellular component
Liver
Mitochondrial ribosome 21 0.58 1.90 0.012 0.038
Microbody 43 0.48 1.92 0.014 0.035
Peroxisome 43 0.48 1.96 0.016 0.026
Organellar ribosome 21 0.58 1.99 0.023 0.018
Ribosomal subunit 19 0.53 1.79 0.032 0.116
Muscle
Pore complex 33 0.51 1.50 0.017 0.917
Proteasome complex 22 0.53 1.48 0.020 0.948
Apicolateral plasma membrane 15 -0.60 -1.78 0.043 0.102
Voltage gated potassium channel
complex
22 -0.56 -1.89 0.052 0.043
Extracellular region 236 -0.32 -1.68 0.060 0.218
KEGG
Liver
Biosynthesis of steroids 22 0.81 2.79 0.000 0.000
Hematopoietic cell lineage 45 -0.62 -1.86 0.007 0.006
Fatty acid metabolism 37 0.48 1.81 0.026 0.057
Butanoate metabolism 37 0.45 1.76 0.029 0.083
Glycerolipid metabolism 39 0.46 1.81 0.038 0.056
Muscle
Metabolism of xenobiotics by
cytochrome P450
23 -0.64 -2.24 0.001 0.001
Complement and coagulation
cascades
34 -0.52 -1.91 0.007 0.024
Ribosome 54 -0.46 -1.93 0.009 0.021
Neuroactive ligand receptor
interaction
86 -0.41 -1.83 0.010 0.046
Alzheimers disease 23 -0.51 -1.76 0.019 0.100
Gene set enrichment analysis (GSEA) was performed in order to detect
differences between liver and skeletal muscle of 4 week old mice subjected to
taurine supplementation during gestation as described in materials and
methods. The top 5 most significant genesets (based on FDR) is shown. Size)
total number of genes in analysis from the geneset. ES) Enrichment score,
reflects the degree to which a gene set is overrepresented. NES) Normalized
enrichment score, is an ES score that is comparable between genesets. A
positive value for ES and NES indicates an upregulation of said geneset by
taurine, likewise a negative value indicates a downregulation of the geneset
in question. FDR) False discovery rate. FWER) Family-wise error rate.
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cantly more mitochondrial genes rescued in skeletal
muscle than in liver, suggesting taurine as an important
factor in the control of mitochondrial gene expression.
Furthermore, we observed thatt h er e s c u i n ge f f e c tw a s
tissue specific, as genes of fatty acid metabolism in the
liver and genes involved in oxidative phosphorylation
and TCA cycle in skeletal muscle were preferentially
r e s c u e dc o m p a r e dw i t ho t h e rg e n e s( T a b l e3a n d4 ) .A
similar study examining the effect of maternal LP diet
and taurine on islet gene expression also found
decreased expression of respiration and TCA cycle
genes, changes which were rescued fully by taurine sup-
plementation [23]. Combined with our results, this
strongly suggests that the effect exerted by taurine is
mediated by a mitochondrial mechanism.
In this context it should be noted that plasma taurine
concentration has been suggested to be a marker of
fetal well being and a prerequisite for normal fetal
development [43]. This is corroborated by the observa-
tion that lack of the taurine transporter (TAUT) confers
a large decrease in exercise capacity [14], which may
also be related to the observation that TAUT expression
increases during myogenesis and that taurine is able to
protect against dexamethasone induced atrophy [44].
Thus, a picture of taurine as a necessary expression fac-
tor in myogenesis, and perhaps in mitochondrial biogen-
esis as well, emerges.
In liver a deficiency of taurine, as seen in the TAUT
knockout mouse, causes an increase in hepatic apoptosis
and inflammation, as well as a decrease in mitochondrial
coupling of oxidative phosphorylation [45]. Also, taurine
has been shown to have an anti-apoptotic effect upon
the liver and to normalize tamoxifen induced mitochon-
drial dysfunction in rats [46]. There are several reports
on the effect of a maternal low protein diet on offspring
DNA methylation patterns [47,48], but there is no
evidence of taurine involvement in this process. Interest-
ingly, taurine has been shown to decrease N-methylation
in rat heart [49].
Taurine supplementation during gestation alone, with
no other dietary manipulations of the maternal diet,
resulted in minute changes to mitochondrial gene
expression in both skeletal muscle and liver, primarily in
lipid metabolism and protein translation. Others have
shown both beneficial [50] and detrimental effects [51]
of gestational taurine supplementation upon the adult
metabolic phenotype, however no mechanism for these
changes have been identified. The observation that
gestational taurine supplementation also in the control
group has an effect on mitochondrial gene expression
and lipid metabolism corroborates the notion of taurine
as being important for development of normal mito-
chondrial function, a field of research which needs more
attention.
Conclusion
A low protein diet to mice during pregnancy caused
major changes in both body mass and gene expression
profiles of liver and skeletal muscle of the newborn
mice. The expression changes were predominantly
related to mitochondrial genes but were markedly differ-
ent in liver and skeletal muscle. Maternal taurine sup-
plementation in the drinking water partially prevented
both the change in body mass and changes in gene
expression. In particular, skeletal muscle genes involved
in oxidative phosphorylation were almost completely
normalized by the taurine supplementation. The
mechanism of these taurine effects remains unknown,
but it may be suggested that taurine is a factor control-
ling mitochondrial gene expression during development,
possibly by an epigenetic mechanism.
Table 6 Mitochondrial genes significantly changed by gestational taurine supplementation in skeletal muscle of 4
week old mice
Probe Gene symbol Gene name Fold change
1428487_s_at COQ10B coenzyme Q10 homolog B 3.04
1416772_at Cpt2 Carnithine palmitoyltransferase 2 1.56
1425140_at Lactb2 Lactamase, beta 2 1.81
1424219_at MRM1 Mitochondrial rRNA methyltransferase 1 1.78
1451266_at Mrpl50 Mitochondrial ribosomal protein L50 1.65
1424433_at Msrb2 Methionine sulfoxide reductase B2 2.21
1449897_a_at MTCP1 Mature T-cell proliferation 1 1.55
1445632_at OGDH Oxoglutarate dehydrogenase (lipoamide) 1.52
1452676_a_at PNPT1 Polyribonucleotide nucleotidyltransferase 1 1.56
1424735_at Slc25a25 Solute carrier family 25 (phosphate carrier), member 25 2.48
1425753_a_at Ung Uracil DNA glycosylase 1.93
A list of probes and corresponding gene symbols and names for mitochondrial genes significantly changed by gestational taurine supplementation. Fold change
indicates the fold change increase in the taurine supplemented group (NP+tau). vs. the non-treated group (NP).
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pdf document. Supplemental table 1. Validation of genes significantly
changed in newborn mice subjected to a maternal low protein diet.
Additional file 2: Mortensen OH LP tau mice additional file 2.xls, Excel
spreadsheet. Supplemental table 2. Genes significantly different in both
liver and skeletal muscle of newborn mice subjected to either a maternal
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genes in liver of newborn mice. All expression values are represented as
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spreadsheet. Supplemental table 4. Significantly changed mitochondrial
genes in skeletal muscle of newborn mice. All expression values are
represented as a single value of fold-change compared to NP.
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